Brivaracetam Solution
Product Images NDC 59651-995

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brivaracetam (NDC 59651-995). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Brivaracetam Fig1)

Bar chart showing reduction in seizure frequency from baseline (%) categorized by placebo and three Brivaracetam dosage groups (50 mg/day, 100 mg/day, 200 mg/day). The y-axis represents the proportion of patients (%), and the x-axis shows categories of seizure frequency reduction ranging from Worse to 75 to 100%. The chart compares patient response proportions across these seizure reduction categories.*

FDA Label Image

Brivaracetam-fig2 (Brivaracetam Fig2)

Label for Brivaracetam Oral Solution 10 mg/mL by Aurobindo Pharma Limited. The 300 mL bottle label states the active ingredient strength, storage instructions, and distributor information for Aurobindo Pharma USA Inc. It includes warnings to keep out of reach of children and advises on medication guides.*

FDA Label Image

Brivaracetam-str (Brivaracetam Str)

Chemical structure diagram of brivaracetam, the active ingredient in the oral solution dosage form of BRIVARACETAM by Aurobindo Pharma Limited.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.